Beyond Air logo
Beyond Air
XAIR | NASDAQ
Chart Builder DCF Calculator
$2.02
-$0.11 (-5.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.92
-$0.10 (-4.95%)
After-hours: Nov 16, 2026, 7:30 PM ET

Beyond Air Company Profile

Company profile explained

Company Profile

Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.

Key Executives

Name Position
Amir Avniel Chief Executive Officer of NeuroNOS
Robert Scott Goodman CEO & Director
Daniel J. Moorhead Chief Financial Officer
Michael A. Gaul Chief Operating Officer
Adam Newman Corporate Secretary
Andrew R. Colin Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
Denton Drewell Principal Accounting Officer & Controller
John Jett Head of Research & Clinical Development

Latest SEC Filings

Date Type Title
Oct 30, 2026 DEFA14A Filing
Oct 30, 2026 DEF 14A Filing
Oct 21, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 20, 2026 PRE 14A Filing
Oct 14, 2026 4 Filing
Oct 08, 2026 8-K Current Report
Oct 02, 2026 4 Filing
Oct 02, 2026 3 Filing
Oct 02, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 24, 2026 8-K Current Report
View All SEC Filings ➞
Beyond Air
Beyond Air logo
Country United States
IPO Date Jun 12, 2018
Industry Medical - Devices
Sector Healthcare
Employees 54
CEO Robert Goodman

Contact Details

900 Stewart Avenue Garden City, New York 11530 United States

Stock Details

Ticker Symbol XAIR
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001641631
CUSIP Number 08862L301
ISIN Number US08862L3015
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.